Media and News

PharmaNova Announces Reorganization
PharmaNova Announces Reorganization Victor, NY  September 11, 2013 --- PharmaNova Inc. announ... Read More »

PharmaNova and Eternity Healthcare Sign Letter of Intent to Develop New Branded Pharmaceuticals
  PharmaNova and Eternity Healthcare Sign Letter of Intent to Develop New Branded Pharmaceutic... Read More »

PharmaNova to Attend BIO International 2013 held at McCormick Place, Chicago, IL, April 22-24, 2013.
 PharmaNova to Attend BIO International 2013 held at McCormick Place, Chicago, IL, April 22-24,... Read More »

PharmaNova to Present at BioTech Showcase 2013 held at the Parc 55 Wyndham, Union Square in San Francisco, CA held on January 7-9 2013.
PharmaNova Inc.will be presenting at the BioTech Showcase 2013 held at the Parc 55 Wyndham, Union Sq... Read More »

PharmaNova to Present at the Biotechnology Symposium held at the Oncenter Complex, Syracuse NY, May 21-22 2012.
PharmaNova Inc. will be presenting at the Biotechnology Symposium held at the Oncenter Complex in Sy... Read More »

PharmaNova’s U.S. Licensee and Partner, Depomed, Inc., Announces Intent to File NDA for Serada for Treatment of Menopausal Hot Flashes.
PharmaNova, Inc. of Victor, New York announced today that its US licensee and development ... Read More »

PharmaNova Fuels Business Growth with Lacerta Bio Partnership
Victor, New York (March 1st., 2011):  PharmaNova, Inc. (PharmaNova) announces an agreement... Read More »

PharmaNova to Present Poster at Controlled Release Product Development Forum on Poorly Soluble Drugs, January 27-28, 2011, Miami FL.
PharmaNova, Inc. of Victor, NY announced that Dr. Deepak Thassu, Chief Scientific Officer and VP... Read More »

PharmaNova, Inc. to Exhibit at the Annual American Association of Pharmaceutical Scientists (AAPS) at 2010 FIP Pharmaceutical Sciences World Congress, New Orleans LA, Morial Convention Center, November 14-18, 2010.
PharmaNova will be exhibiting NovaSperse℠ nanoparticle technology capabilities at the Annual A... Read More »

NovaSperse℠ Nanoparticle Innovator, PharmaNova, Inc. Awarded Four Government Grants toward Development of New Therapeutic Products under Congressional Qualifying Therapeutic Discovery Project Initiative.
NovaSperse℠ Nanoparticle Innovator, PharmaNova, Inc.  Awarded Four Government Grants towa... Read More »

PharmaNova’s U.S. Licensee and Partner for Menopause Treatment, Depomed, Inc. Starts Final Phase 3 Hot Flash Trial Enrollment after SPA Agreement with FDA.
PharmaNova’s U.S. Licensee and Partner for Menopause Treatment, Depomed, Inc. Starts Fina... Read More »

PharmaNova’s U.S. Licensee and Partner for Menopause Treatment, Depomed, Inc., Announces Anticipated September 2010 Enrollment for Final Phase 3 Clinical Trial.
PharmaNova’s U.S. Licensee and Partner for Menopause Treatment, Depomed, Inc., Announces Antic... Read More »

PharmaNova Invited to Speak at the Controlled Release Society (CRS) Soapbox Session Innovations Sunday Series in Portland, Oregon, July 11, 2010
June 2, 2010 PharmaNova Invited to Speak at the Controlled Release Society (CRS) Soapbox Session In... Read More »

PharmaNova to Exhibit at Annual Controlled Release Society (CRS) Meeting in Portland, Oregon July 10-14, 2010
PharmaNova to Exhibit at Annual Controlled Release Society (CRS) Meeting in Portland, Oregon July 10... Read More »

PharmaNova, Inc. to Present on “Nanoparticle Formulations to Enhance Ophthalmic Drug Delivery” at New York Biotechnology Association (NYBA) Annual Meeting in New York City, Marriot Marquis, Times Square, April 19-20 2010.
PharmaNova, Inc. to Present on “Nanoparticle Formulations to Enhance Ophthalmic Drug Delivery&... Read More »

PharmaNova, Inc. Announces Acceptance of Publication of Dr. Deepak Thassu’s Book, Ocular Drug Delivery System: Barriers and Application of Nanoparticulate Systems
PharmaNova, Inc. of Victor, NY announced today, March 15, 2010, Dr. Deepak Thassu’s book, Ocul... Read More »

PharmaNova to Present at Annual American Association of Pharmaceutical Scientists (AAPS) at 2010 FIP Pharmaceutical Sciences World Congress, New Orleans LA, November 14-18, 2010
PharmaNova to Present at Annual American Association of Pharmaceutical Scientists (AAPS) at 2010 FIP... Read More »

PharmaNova’s U.S Development and Commercial Partner, Depomed Inc., Comments on FDA Guidance and Plans for One Additional Phase 3 Clinical Trial Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes Under the FDA’s Special Protocol Assessment (SPA)
PharmaNova’s U.S Development and Commercial Partner, Depomed Inc., Comments on FDA Guidance an... Read More »

PharmaNova Featured in January 2010 Drug Delivery Technology Journal as Rising Drug Delivery Company
PharmaNova Inc of Victor, New York recognized in the January 2010 issue of Drug Delivery Technology ... Read More »

PharmaNova to exhibit at AAPS Annual Convention, Los Angeles, CA November 8-12, 2009
PharmaNova Inc. will be exhibiting at the AAPS Annual Convention to be held in the Los Angeles Conve... Read More »

PharmaNova to present at Life Sciences Summit 2009, Long Island, NY September 23-24
Rodney A. Brown, President, PharmaNova Inc. will be a presenting delegate at the Life Sciences Summi... Read More »

PharmaNova, Inc.  and Altacor Ltd., form Strategic Alliance to develop new ophthalmic medicines.
PharmaNova Inc., (PharmaNova), of Rochester, New York, USA, and Altacor Ltd., (Altacor), of Cambridg... Read More »

Debut of PharmaNova’s NovaSpersesm at AAPS Annual Meeting in Atlanta
PharmaNova will be unveiling its new drug delivery technology NovaSpersesm at the AAPS meeting in At... Read More »

PharmaNova to exhibit at AAPS Annual Convention, Atlanta, GA.  – November 16-20, 2008.
PharmaNova Inc. will be exhibiting at the AAPS Annual Convention to be held in Atlanta’s Georg... Read More »

PHARMANOVA’S LICENSEE INITIATES PHASE 3 CLINICAL PROGRAM FOR NON-HORMONAL MENOPAUSAL HOT FLASH TREATMENT
PharmaNova’s licensee, Depomed, Inc., announced today the initiation of the first of two pivot... Read More »

PharmaNova to present at BioPartnering Europe 2008
PharmaNova, Inc. and our affiliate company PharmaNova Europa Ltd. will be presenting and exhibiting ... Read More »

PharmaNova to exhibit at Bio-2008: San Diego Convention Center – June 17-20, 2008.
PharmaNova Inc. will be exhibiting in the NY State Bio Pavilion at the 2008 Bio International Confer... Read More »

Rochester, NY, January 25th. 2008: PharmaNova, Inc. Appoints Deepak Thassu as Vice-President, Pharmaceutical Development.
Press release:  Rochester, NY, January 25th. 2008. PharmaNova, Inc. Appoints Deepak Thassu as V... Read More »

PharmaNova to present at UK conference, BioPartnering Europe 2007.
Rochester, New York: August 17, 2007.  PharmaNova Inc. announced today that the company&... Read More »

Rochester, NY: PharmaNova partners with diagnostics and device company, Rochester Innovations
PharmaNova Inc. announced today that it has entered into a collaboration with Rochester Innovations ... Read More »

PharmaNova expands into new lab. facilities to accelerate its nanoparticle R&D. See "Contact us" for new address.
... Read More »

PharmaNova forms Strategic Alliance with Taiwan based Orient Europharma
PharmaNova Inc., announced today that it has formed a strategic alliance and collaboration with Orie... Read More »

PHARMANOVA'S LICENSEE DEPOMED FILES INVESTIGATIONAL NEW DRUG APPLICATION FOR GABAPENTIN GR FOR THE TREATMENT OF POSTMENOPAUSAL HOT FLASHES
MENLO PARK, Calif., Mar 12, 2007 (BUSINESS WIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced today that... Read More »

View Media Archive »



Member of the media wishing to learn more about Pharmanova should contact:
Rafael Larramendi, President | ral@rochester.rr.com | (585) 919 -9649.